Evidence map›Paper›PMID 41511347›Full record

ReviewCells2025

Protein Kinase A Signaling in Cortisol Production and Adrenal Cushing's Syndrome.

Abhishek Kumar, Abhimanyu Sharma, Mitchell H Omar

Abstract readReview
In one paragraph

Review in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abhishek KumarDepartment of Biochemistry, Molecular Biology, and Biotechnology, University of Nevada, Reno, NV 89557, USA.ORCID 0009-0004-7801-7221
Abhimanyu SharmaDepartment of Biochemistry, Molecular Biology, and Biotechnology, University of Nevada, Reno, NV 89557, USA.ORCID 0000-0003-2057-8494
Mitchell H OmarDepartment of Biochemistry, Molecular Biology, and Biotechnology, University of Nevada, Reno, NV 89557, USA.ORCID 0000-0002-1713-4473

Funding

Transgenic Animal Genotyping and Phenotyping CoreP20GM130459 · NIGMS · UNIVERSITY OF NEVADA RENO · PI Yumei Feng Earley · 2019 to 2026
$20.3M
Diabetes, Obesity and Metabolism Training ProgramT32DK007247 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, KRISTINA Marie UTZSCHNEIDER · 1986 to 2026
$10.0M
NIDDK NIH HHS T32 DK007247NIGMS NIH HHS P20 GM130459NIGMS NIH HHS P20GM130459
6 · The paper itself

Abstract

The adenosine 3',5'-cyclic monophosphate-protein kinase A (cAMP-PKA) signaling pathway is highly utilized in human physiology. It is a crucial component of development and is vital to cellular function in nearly all tissues. Indeed, genetic mutations to cAMP-PKA machinery are found in many pathologies, including multiple cancers, cardiac myxoma, neurodevelopmental disorders, and hypercortisolism. Cyclic AMP and PKA were first identified as vital components in cortisol synthesis over 50 years ago, yet the cellular mechanisms connecting PKA to cortisol production are still not well understood. This article will review evidence for PKA's roles in adrenal gland zona fasciculata steroidogenesis and consider recent studies of the stress hormone disease adrenal Cushing's syndrome to synthesize a current model for cAMP-PKA actions in cortisol production.

Indexed as

Adrenal GlandsCushing SyndromeCyclic AMP-Dependent Protein KinasesHydrocortisoneSignal TransductionAnimalsCyclic AMPHumansCyclic AMPCyclic AMP-Dependent Protein KinasesHydrocortisoneadrenalcAMPcortisolCushingcyclic AMPglucocorticoidsPKAprotein kinase A

Identifiers

PMID41511347
PMCPMC12785293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.